LEVOMEPROMAZINE HYDROCHLORIDE


Synonyms	Levomepromazine hcl Levomepromazine hydrochloride Methotrimeprazine hydrochloride Nozinan
Status
Molecule Category	Salt-form
UNII	42BB1Y2586

Structure


InChI Key	ODLGFPIWRAEFAN-PFEQFJNWSA-N
Smiles	COc1ccc2c(c1)N(C[C@H](C)CN(C)C)c1ccccc1S2.Cl
InChI	InChI=1S/C19H24N2OS.ClH/c1-14(12-20(2)3)13-21-16-7-5-6-8-18(16)23-19-10-9-15(22-4)11-17(19)21;/h5-11,14H,12-13H2,1-4H3;1H/t14-;/m1./s1

Physicochemical Descriptors

Property Name	Value
Molecular Formula	C19H25ClN2OS
Molecular Weight	364.94
AlogP	4.5
Hydrogen Bond Acceptor	4.0
Number of Rotational Bond	5.0
Polar Surface Area	15.71
Molecular species	BASE
Aromatic Rings	2.0
Heavy Atoms	23.0

Cross References

Resources	Reference
ChEBI	31773
ChEMBL	CHEMBL2104973
FDA SRS	42BB1Y2586
PubChem	11954230
SureChEMBL	SCHEMBL418079

CONTENTS


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).